The mechanism of action of delta sleep-inducing peptide (DSIP) remains poorly understood, but it is hypothesized to modulate neurotransmitter systems, particularly through adrenergic transmission, potentially involving receptors in the hypothalamic parvocellular paraventricular nucleus (pPVN) and limbic structures. DSIP appears to influence Fos expression, which is linked to stress response pathways, suggesting a role in neuroendocrine regulation and sleep promotion, although specific receptor interactions and signaling pathways remain to be fully elucidated. Additionally, DSIP's effects on neurotransmitter levels, such as serotonin and dopamine, indicate involvement in sleep regulation and emotional stress responses, but definitive mechanisms are still unresolved.